Table of Contents
ISRN Microbiology
Volume 2012, Article ID 978607, 11 pages
http://dx.doi.org/10.5402/2012/978607
Research Article

Important Roles of Cellular MicroRNA miR-155 in Leukemogenesis by Human T-Cell Leukemia Virus Type 1 Infection

Department of Pathology and Oncology, Graduate School of Medical Science, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa 903-0215, Japan

Received 3 July 2012; Accepted 13 August 2012

Academic Editors: C. K. Cote, T. Krishnan, and A. Tavanti

Copyright © 2012 Mariko Tomita. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Matsuoka and K. T. Jeang, “Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation,” Nature Reviews Cancer, vol. 7, no. 4, pp. 270–280, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. K. Tajima, “The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan: estimates of risk of ATL and its geographical and clinical features,” International Journal of Cancer, vol. 45, no. 2, pp. 237–243, 1990. View at Google Scholar · View at Scopus
  3. Y. Yamada, M. Tomonaga, H. Fukuda et al., “A new G-CSF-supported combination chemotherapy, LSG15, for adult T-cell leukaemia-lymphoma: Japan clinical oncology group study 9303,” British Journal of Haematology, vol. 113, no. 2, pp. 375–382, 2001. View at Publisher · View at Google Scholar · View at Scopus
  4. R. Grassmann, S. Berchtold, I. Radant et al., “Role of human T-cell leukemia virus type 1 X region proteins in immortalization of primary human lymphocytes in culture,” Journal of Virology, vol. 66, no. 7, pp. 4570–4575, 1992. View at Google Scholar · View at Scopus
  5. H. Hasegawa, H. Sawa, M. J. Lewis et al., “Thymus-derived leukemia-lymphoma in mice transgenic for the tax gene of human T-lymphotropic virus type I,” Nature Medicine, vol. 12, no. 4, pp. 466–472, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. I. Azran, Y. Schavinsky-Khrapunsky, and M. Aboud, “Role of tax protein in human T-cell leukemia virus type-I leukemogenicity,” Retrovirology, vol. 1, article 20, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Grassmann, M. Aboud, and K. T. Jeang, “Molecular mechanisms of cellular transformation by HTLV-1 Tax,” Oncogene, vol. 24, no. 39, pp. 5976–5985, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Esquela-Kerscher and F. J. Slack, “Oncomirs—microRNAs with a role in cancer,” Nature Reviews Cancer, vol. 6, no. 4, pp. 259–269, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. G. A. Calin and C. M. Croce, “MicroRNA signatures in human cancers,” Nature Reviews Cancer, vol. 6, no. 11, pp. 857–866, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. C. M. Croce, “Causes and consequences of microRNA dysregulation in cancer,” Nature Reviews Genetics, vol. 10, no. 10, pp. 704–714, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Lu, G. Getz, E. A. Miska et al., “MicroRNA expression profiles classify human cancers,” Nature, vol. 435, no. 7043, pp. 834–838, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Greither, L. F. Grochola, A. Udelnow, C. Lautenschläger, P. Würl, and H. Taubert, “Elevated expression of microRNAs 155, 203, 210 and 222 in pancreatic tumors is associated with poorer survival,” International Journal of Cancer, vol. 126, no. 1, pp. 73–80, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Pfeffer and O. Voinnet, “Viruses, microRNAs and cancer,” Oncogene, vol. 25, no. 46, pp. 6211–6219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Grassmann and K. T. Jeang, “The roles of microRNAs in mammalian virus infection,” Biochimica et Biophysica Acta, vol. 1779, no. 11, pp. 706–711, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. M. L. Yeung, J. I. Yasunaga, Y. Bennasser et al., “Roles for microRNAs, miR-93 and miR-130b, and tumor protein 53-induced nuclear protein 1 tumor suppressor in cell growth dysregulation by human T-cell lymphotrophic virus 1,” Cancer Research, vol. 68, no. 21, pp. 8976–8985, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Pichler, G. Schneider, and R. Grassmann, “MicroRNA miR-146a and further oncogenesis-related cellular microRNAs are dysregulated in HTLV-1-transformed T lymphocytes,” Retrovirology, vol. 5, article 100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. M. Bellon, Y. Lepelletier, O. Hermine, and C. Nicot, “Deregulation of microRNA involved in hematopoiesis and the immune response in HTLV-I adult T-cell leukemia,” Blood, vol. 113, no. 20, pp. 4914–4917, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. A. van den Berg, B. J. Kroesen, K. Kooistra et al., “High expression of B-cell receptor inducible gene BIC in all subtypes of hodgkin lymphoma,” Genes Chromosomes and Cancer, vol. 37, no. 1, pp. 20–28, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Kluiver, S. Poppema, D. de Jong et al., “BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas,” Journal of Pathology, vol. 207, no. 2, pp. 243–249, 2005. View at Publisher · View at Google Scholar · View at Scopus
  21. P. S. Eis, W. Tam, L. Sun et al., “Accumulation of miR-155 and BIC RNA in human B cell lymphomas,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 10, pp. 3627–3632, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Rodriguez, E. Vigorito, S. Clare et al., “Requirement of bic/microRNA-155 for normal immune function,” Science, vol. 316, no. 5824, pp. 608–611, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. D. Haasch, Y. W. Chen, R. M. Reilly et al., “T cell activation induces a noncoding RNA transcript sensitive to inhibition by immunosuppressant drugs and encoded by the proto-oncogene, BIC,” Cellular Immunology, vol. 217, no. 1-2, pp. 78–86, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Costinean, N. Zanesi, Y. Pekarsky et al., “Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 18, pp. 7024–7029, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Nagata, K. Ohtani, M. Nakamura, and K. Sugamura, “Activation of endogenous c-fos proto-oncogene expression by human T-cell leukemia virus type I-encoded p40(tax) protein in the human T-cell line, Jurkat,” Journal of Virology, vol. 63, no. 8, pp. 3220–3226, 1989. View at Google Scholar · View at Scopus
  26. Y. Tanaka, K. Fukudome, M. Hayashi, S. Takagi, and O. Yoshie, “Induction of ICAM-1 and LFA-3 by Tax1 of human T-cell leukemia virus type 1 and mechanism of down-regulation of ICAM-1 or LFA-1 in adult-T-cell-leukemia cell lines,” International Journal of Cancer, vol. 60, no. 4, pp. 554–561, 1995. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Tanaka, A. Yoshida, Y. Takayama et al., “Heterogeneity of antigen molecules recognized by anti-tax1 monoclonal antibody Lt-4 in cell lines bearing human T cell leukemia virus type I and related retroviruses,” Japanese Journal of Cancer Research, vol. 81, no. 3, pp. 225–231, 1990. View at Google Scholar · View at Scopus
  28. M. Tomita, Y. Tanaka, and N. Mori, “MicroRNA miR-146a is induced by HTLV-1 tax and increases the growth of HTLV-1-infected T-cells,” International Journal of Cancer, vol. 130, no. 10, pp. 2300–2309, 2010. View at Publisher · View at Google Scholar
  29. C. Chen, D. A. Ridzon, A. J. Broomer et al., “Real-time quantification of microRNAs by stem-loop RT-PCR,” Nucleic Acids Research, vol. 33, no. 20, pp. e179.1–e179.9, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Tomita, J. Choe, T. Tsukazaki, and N. Mori, “The Kaposi's sarcoma-associated herpesvirus K-bZIP protein represses transforming growth factor β signaling through interaction with CREB-binding protein,” Oncogene, vol. 23, no. 50, pp. 8272–8281, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Harrod, Y. Tang, C. Nicot et al., “An exposed KID-like domain in human T-cell lymphotropic virus type 1 tax is responsible for the recruitment of coactivators CBP/p300,” Molecular and Cellular Biology, vol. 18, no. 9, pp. 5052–5061, 1998. View at Google Scholar · View at Scopus
  33. K. Matsumoto, H. Shibata, J. I. Fujisawa et al., “Human T-cell leukemia virus type 1 Tax protein transforms rat fibroblasts via two distinct pathways,” Journal of Virology, vol. 71, no. 6, pp. 4445–4451, 1997. View at Google Scholar · View at Scopus
  34. Q. Yin, J. McBride, C. Fewell et al., “MicroRNA-155 is an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways,” Journal of Virology, vol. 82, no. 11, pp. 5295–5306, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. T. M. Antalis and D. Godbolt, “Isolation of intact nuclei from hematopoietic cell types,” Nucleic Acids Research, vol. 19, no. 15, p. 4301, 1991. View at Google Scholar · View at Scopus
  36. N. Mori and D. Prager, “Transactivation of the interleukin-1α promoter by human T-cell leukemia virus type I and type II tax proteins,” Blood, vol. 87, no. 8, pp. 3410–3417, 1996. View at Google Scholar · View at Scopus
  37. K. Iwai, N. Mori, M. Oie, N. Yamamoto, and M. Fujii, “Human T-cell leukemia virus type 1 Tax protein activates transcription through AP-1 site by inducing DNA binding activity in T cells,” Virology, vol. 279, no. 1, pp. 38–46, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. R. L. Skalsky, M. A. Samols, K. B. Plaisance et al., “Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155,” Journal of Virology, vol. 81, no. 23, pp. 12836–12845, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. E. Gottwein, N. Mukherjee, C. Sachse et al., “A viral microRNA functions as an orthologue of cellular miR-155,” Nature, vol. 450, no. 7172, pp. 1096–1099, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. J. Jiang, J. L. Eun, and T. D. Schmittgen, “Increased expression of microRNA-155 in Epstein-Barr virus transformed lymphoblastoid cell lines,” Genes Chromosomes and Cancer, vol. 45, no. 1, pp. 103–106, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. G. Gatto, A. Rossi, D. Rossi, S. Kroening, S. Bonatti, and M. Mallardo, “Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF-κB pathway,” Nucleic Acids Research, vol. 36, no. 20, pp. 6608–6619, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. F. Lu, A. Weidmer, C. G. Liu, S. Volinia, C. M. Croce, and P. M. Lieberman, “Epstein-Barr virus-induced miR-155 attenuates NF-κB signaling and stabilizes latent virus persistence,” Journal of Virology, vol. 82, no. 21, pp. 10436–10443, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. R. Kanezaki, T. Toki, M. Yokoyama et al., “Transcription factor BACH1 is recruited to the nucleus by its novel alternative spliced isoform,” Journal of Biological Chemistry, vol. 276, no. 10, pp. 7278–7284, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. N. Mori, M. Fujii, K. Iwai et al., “Constitutive activation of transcription factor AP-1 in primary adult T- cell leukemia cells,” Blood, vol. 95, no. 12, pp. 3915–3921, 2000. View at Google Scholar · View at Scopus
  45. Z. Lin and E. K. Flemington, “miRNAs in the pathogenesis of oncogenic human viruses,” Cancer Letters, vol. 305, no. 2, pp. 186–199, 2011. View at Publisher · View at Google Scholar · View at Scopus
  46. A. Itkes, C. J. Allegra, and M. Zajac-Kaye, “Multiprotein complexes present at the MIF motifs flanking the promoter of the human c-myc gene,” FEBS Letters, vol. 474, no. 1, pp. 23–28, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. M. P. Duyao, D. J. Kessler, D. B. Spicer et al., “Transactivation of the c-myc promoter by human T cell leukemia virus type 1 tax is mediated by NFκB,” Journal of Biological Chemistry, vol. 267, no. 23, pp. 16288–16291, 1992. View at Google Scholar · View at Scopus
  48. M. Yamagishi, K. Nakano, A. Miyake et al., “Polycomb-mediated loss of miR-31 activates NIK-dependent NF-κB pathway in adult T cell leukemia and other cancers,” Cancer Cell, vol. 21, no. 1, pp. 121–135, 2012. View at Google Scholar